UNLIMITED TURBO BULL - CANSINO BIOLOGICS H | Market Closed - Euronext Paris 12:30:00 2024-05-22 EDT | ||
| 1.11 EUR | +7.77% |
|
| Current month | +53.10% | ||
| 1 month | +57.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CANSINO BIOLOGICS INC.
Latest news about CANSINO BIOLOGICS INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 1.11 | +7.77% |
| 24-05-21 | 1.03 | -11.97% |
| 24-05-20 | 1.17 | +0.86% |
| 24-05-17 | 1.16 | +0.87% |
| 24-05-16 | 1.15 | +1.77% |
Real-time Euronext Paris
Last update May 22, 2024 at 12:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | CANSINO BIOLOGICS INC. |
| Issuer | 
Société Générale
|
| U646S | |
| ISIN | DE000SU67451 |
| Date issued | 2024-01-22 |
| Strike | 11.83 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.76 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.225 € |
|---|---|
| Lowest since issue | 0.44 € |
Company Profile
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Sector
-
Consensus: CanSino Biologics Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
19.8
CNY
Average target price
25.66
CNY
Spread / Average Target
+29.59%
- Stock Market
- Certificates
- U646S Certificat
